Dressings for chronic wounds

Dermatologic Therapy

Volumn 26, Issue 3, 2013, Pages 197-206

  Powers, Jennifer Gloeckner ^a   Morton, Laurel M ^b   Phillips, Tania J ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic wounds; moisture retentive dressings; wound dressings

Indexed keywords

ALGINIC ACID; CADEXOMER IODINE; COLLAGENASE; MACROGOL;

ANGIOGENESIS; ARTICLE; CHRONIC WOUND; GEL; HONEY; HUMAN; HYDROCOLLOID; HYDROGEL; MAGGOT; SILVER DRESSING; WOUND DRESSING;

ALGINATES; ANTI-INFECTIVE AGENTS; BANDAGES; CHRONIC DISEASE; COLLOIDS; HUMANS; HYDROGELS; WOUNDS AND INJURIES;

EID: 84878795775     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12055     Document Type: Article

References (61)

1. Schreml S, Szeimies RM, Prantl L, Landthaler M, Babilas P,. Wound healing in the 21st century. J Am Acad Dermatol 2010: 63: 866-881.
2. Broughton G 2nd, Janis JE, Attinger CE,. A brief history of wound care. Plast Reconstr Surg 2006: 117: 6S-11S.
3. Thorne VB,. When boiling oil cured wounds. New York Times, 23 October 1921.
4. Del Rosso JQ,. Wound care in the dermatology office: where are we in 2011? J Am Acad Dermatol 2011: 64: S1-S7.
5. Stewart J,. Appreciation of Sir John Rickman Godlee's life of lord lister. Can Med Assoc J 1918: 8: 753-757.
6. Curtis TB,. Cotton-wool dressings for wounds. Boston Med Surg J 1874: 91: 197-207.
7. Odland GF,. The fine structure of the interrelationship of cells in the human epidermis. J Biophys Biochem Cytol 1958: 4: 529-538.
8. Winter GD,. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962: 193: 293-294.
9. Hinman CD, Maibach H,. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963: 200: 377-378.
10. Bolton LL, Johnson CL, Van Rijswijk L,. Occlusive dressings: therapeutic agents and effects on drug delivery. Clin Dermatol 1991: 9: 573-583.
11. Kirsner RS,. Wound healing. In:, Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology, 2nd ed. London: Mosby, 2008: 2147-2158.
12. Zhao M, Song B, Pu J, et al. Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN. Nature 2006: 442: 457-460.
13. Huttenlocher A, Horwitz AR,. Wound healing with electric potential. N Engl J Med 2007: 356: 303-304.
14. Nemeth AJ, Eaglstein WH, Taylor JR, Peerson LJ, Falanga V,. Faster healing and less pain in skin biopsy sites treated with an occlusive dressing. Arch Dermatol 1991: 127: 1679-1683.
15. Chaby G, Senet P, Vaneau M, et al. Dressings for acute and chronic wounds: a systematic review. Arch Dermatol 2007: 143: 1297-1304.
16. Cordts PR, Hanrahan LM, Rodriguez AA, Woodson J, LaMorte WW, Menzoian JO,. A prospective, randomized trial of Unna's boot versus Duoderm CGF hydroactive dressing plus compression in the management of venous leg ulcers. J Vasc Surg 1992: 15: 480-486.
17. Ohlsson P, Larsson K, Lindholm C, Moller M,. A cost-effectiveness study of leg ulcer treatment in primary care. Comparison of saline-gauze and hydrocolloid treatment in a prospective, randomized study. Scand J Prim Health Care 1994: 12: 295-299.
18. Brown KL, Leveriza-Oh M, Phillips TJ,. Dressings and postoperative care. In:, Robinson JK, Hanke CW, Siegel DM, Fratila A, eds. Surgery of the skin: procedural dermatology, 2nd ed. Philadelphia: Elsevier Inc., 2010: 117-136.
19. Lionelli GT, Lawrence WT,. Wound dressings. Surg Clin North Am 2003: 83: 617-638.
20. Rakel BA, Bermel MA, Abbott LI, et al. Split-thickness skin graft donor site care: a quantitative synthesis of the research. Appl Nurs Res 1998: 11: 174-182.
21. Bello YM, Phillips TJ,. Management of venous ulcers. J Cutan Med Surg 1998: 3 (Suppl. 1): 6-12.
22. Meaume S, Ourabah Z, Cartier H, et al. Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers. J Wound Care 2005: 14: 329-334.
23. Grange-Prunier A, Couilliet D, Grange F, Guillaume JC,. [Allergic contact dermatitis to the Comfeel hydrocolloid dressing]. Ann Dermatol Venereol 2002: 129: 725-727.
24. Bradley M, Cullum N, Nelson EA, Petticrew M, Sheldon T, Torgerson D,. Systematic reviews of wound care management: (2). Dressings and topical agents used in the healing of chronic wounds. Health Technol Assess 1999: 3: 1-35.
25. Singh A, Halder S, Menon GR, et al. Meta-analysis of randomized controlled trials on hydrocolloid occlusive dressing versus conventional gauze dressing in the healing of chronic wounds. Asian J Surg/Asian Surg Assoc 2004: 27: 326-332.
26. Bouza C, Saz Z, Munoz A, Amate JM,. Efficacy of advanced dressings in the treatment of pressure ulcers: a systematic review. J Wound Care 2005: 14: 193-199.
27. Blair SD, Jarvis P, Salmon M, McCollum C,. Clinical trial of calcium alginate haemostatic swabs. Br J Surg 1990: 77: 568-570.
28. Belmin J, Meaume S, Rabus MT, Bohbot S,. Sequential treatment with calcium alginate dressings and hydrocolloid dressings accelerates pressure ulcer healing in older subjects: a multicenter randomized trial of sequential versus nonsequential treatment with hydrocolloid dressings alone. J Am Geriatr Soc 2002: 50: 269-274.
29. Sayag J, Meaume S, Bohbot S,. Healing properties of calcium alginate dressings. J Wound Care 1996: 5: 357-362.
30. Lalau JD, Bresson R, Charpentier P, et al. Efficacy and tolerance of calcium alginate versus vaseline gauze dressings in the treatment of diabetic foot lesions. Diabetes Metab 2002: 28: 223-229.
31. Coats TJ, Edwards C, Newton R, Staun E,. The effect of gel burns dressings on skin temperature. Emerg Med J 2002: 19: 224-225.
32. Achterberg V, Meyer-Ingold W,. Hydroactive dressings and serum proteins: an in vitro study. J Wound Care 1996: 5: 79-82.
33. Hermans MH,. Silver-containing dressings and the need for evidence. Am J Nurs 2006: 106: 60-68; quiz 8-9.
34. Russell AD, Hugo WB,. Antimicrobial activity and action of silver. Prog Med Chem 1994: 31: 351-370.
35. Carter MJ, Tingley-Kelley K, Warriner RA 3rd,. Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: a systematic review and meta-analysis. J Am Acad Dermatol 2010: 63: 668-679.
36. Bergin SM, Wraight P,. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev 2006: Jan 25 (1): CD005082.
37. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H,. Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010: Mar 17 (3): CD006478.
38. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT,. Topical silver for treating infected wounds. Cochrane Database Syst Rev 2007: Jan 24 (1): CD005486.
39. Tian J, Wong KK, Ho CM, et al. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007: 2: 129-136.
40. Cortivo R, Vindigni V, Iacobellis L, Abatangelo G, Pinton P, Zavan B,. Nanoscale particle therapies for wounds and ulcers. Nanomedicine (Lond) 2010: 5: 641-656.
41. Lipsky BA, Hoey C,. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 2009: 49: 1541-1549.
42. O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG,. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2010: Jan 20 (1): CD003557.
43. Poskitt KR, James AH, Lloyd-Davies ER, Walton J, McCollum C,. Pinch skin grafting or porcine dermis in venous ulcers: a randomised clinical trial. Br Med J (Clin Res Ed) 1987: 294: 674-676.
44. Enoch S, Grey JE, Harding KG,. Recent advances and emerging treatments. BMJ 2006: 332: 962-965.
45. Veves A, Sheehan P, Pham HT,. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs. standard treatment in the management of diabetic foot ulcers. Arch Surg 2002: 137: 822-827.
46. Barrett SA, Moore K,. Use of Promogran to treat venous leg ulcers. J Wound Care 2004: 13: S2-S7.
47. Nisi G, Brandi C, Grimaldi L, Calabro M, D'Aniello C,. Use of a protease-modulating matrix in the treatment of pressure sores. Chir Ital 2005: 57: 465-468.
48. Jull AB, Rodgers A, Walker N,. Honey as a topical treatment for wounds. Cochrane Database Syst Rev 2008: Oct 8 (4): CD005083.
49. Demidova-Rice TN, Geevarghese A, Herman IM,. Bioactive peptides derived from vascular endothelial cell extracellular matrices promote microvascular morphogenesis and wound healing in vitro. Wound Repair Regen 2011: 19: 59-70.
50. Konig M, Vanscheidt W, Augustin M, Kapp H,. Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. J Wound Care 2005: 14: 320-323.
51. Andersen AS, Sandvang D, Schnorr KM, et al. A novel approach to the antimicrobial activity of maggot debridement therapy. J Antimicrob Chemother 2010: 65: 1646-1654.
52. Margolin L, Gialanella P,. Assessment of the antimicrobial properties of maggots. Int Wound J 2010: 7: 202-204.
53. Steenvoorde P, Jukema GN,. The antimicrobial activity of maggots: in-vivo results. J Tissue Viability 2004: 14: 97-101.
54. Dumville JC, Worthy G, Soares MO, et al. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers. Health Technol Assess 2009: 13: 1-182, iii-iv.
55. Soares MO, Iglesias CP, Bland JM, et al. Cost effectiveness analysis of larval therapy for leg ulcers. BMJ 2009: 338: b825.
56. Spilsbury K, Cullum N, Dumville J, O'Meara S, Petherick E, Thompson C,. Exploring patient perceptions of larval therapy as a potential treatment for venous leg ulceration. Health Expect 2008: 11: 148-159.
57. Boateng JS, Matthews KH, Stevens HN, Eccleston GM,. Wound healing dressings and drug delivery systems: a review. J Pharm Sci 2008: 97: 2892-2923.
58. Friedman A,. Wound healing: from basic science to clinical practice and beyond. J Drugs Dermatol 2011: 10: 427-433.
59. Wieman TJ, Smiell JM, Su Y,. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998: 21: 822-827.
60. Papanas N, Maltezos E,. Benefit-risk assessment of becaplermin in the treatment of diabetic foot ulcers. Drug Saf 2010: 33: 455-461.
61. Uchi H, Igarashi A, Urabe K, et al. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 2009: 19: 461-468.